Text Size

Novel use of a chemically modified siRNA for robust and sustainable in vivo gene silencing in the retina

Taniguchi T., Endo K.-I., Tanioka H., Sasaoka M., Tashiro K., Kinoshita S., Kageyama M.

  • 2020
  • Scientific Reports
View publication
  • Therapeutic Area

    Back of the eye (BOTE)

  • Technology

    Drug Delivery

  • Categories

    Preclinical development

  • Affiliations

    Research and Development Division, Santen Pharmaceutical Co., Ltd., 8916-16 Takayama-cho, Ikoma-shi, Nara, 630-0101, Japan; Global Alliances and External Research, Santen Pharmaceutical Co., Ltd, Nara, Japan; Department of Genomic Medical Sciences, Kyoto Prefectural University of Medicine, Kyoto, Japan; Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan

Related Publications

Tiny dexamethasone palmitate nanoparticles for intravitreal injection: optimization and in vivo evaluation

Canioni R., Reynaud F. , Leite-Nascimento T. , Gueutin C., Guiblin N. , Ghermani N-E. , Jayat C. , Daull P. , Garrigue J-S. , Fattal E. , Tsapis N.

Ultrathin polyimide membrane as cell carrier for subretinal transplantation of human embryonic stem cell derived retinal pigment epithelium

Ilmarinen T., Hiidenmaa H., Kööbi P., Nymark S., Sorkio A., Wang J.-H., Stanzel B.V., Thieltges F., Alajuuma P., Oksala O., Kataja M., Uusitalo H., Skottman H.

Photoreceptor rescue of pigment epithelium-derived factor-impregnated nanoparticles in Royal College of Surgeons rats

Akiyama G., Sakai T., Kuno N., Kimura E., Okano K., Kohno H., Tsuneoka H.

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022